HIV drug resistance and risk factors associated with first-line regimen failure in Maputo and Tete, Mozambique
Principal investigator
-
Location
-
Topic
-
Methodology
-
ReferenceOCB1715
-
Views196
-
Downloaded0
Purpose of study
Purpose of study
The global scale-up of antiretroviral therapy has led to a growing number of people under treatment, notably in sub-Saharan Africa. Despite good short-term health outcomes, antiretroviral therapy (ART) roll-out is accelerating the number of pati...
Study status
Study timeline
Documents
Publications
-
High level of HIV drug resistance informs dolutegravir roll-out and optimized NRTI backbone strategy in MozambiqueCarnimeo, V "–" Oxford University Press (OUP) "(2021)"
Previous study
Next study